BRAIN RELAPSE IN HER2-POSITIVE BREAST CANCER AFTER NEOADJUVANT TREATMENT: AN INTERNATIONAL MULTICENTRIC STUDY

被引：1

作者：

Fortuna, A. ^{[1
]}

Nobre Carvalho, A. ^{[2
]}

Soares de Pinho, I. ^{[3
]}

Lopes-Bras, R. ^{[3
]}

Patel, V. ^{[3
]}

Esperanca-Martins, M. ^{[3
]}

Goncalves, L. ^{[3
]}

Freitas, R. ^{[4
]}

Simao, D. ^{[5
]}

Roldan Galnares, M. ^{[6
]}

Fernandes, I. ^{[7
]}

Artacho Criado, S. ^{[6
]}

Gamez Casado, S. ^{[8
]}

Baena Canada, J. ^{[8
]}

Saffie Vega, I. M. ^{[9
]}

Costa, J. ^{[10
]}

Fernandes, A. S. ^{[10
]}

Teixeira de Sousa, R. ^{[3
]}

Costa, L. ^{[3
]}

Luz, P. ^{[1
,10
,11
]}

机构：

[1] Ctr Hosp Univ Algarve, Faro, Portugal

[2] Ctr Hosp Entre Douro e Vouga, Med Oncol, EPE, Santa Maria, RS, Portugal

[3] Hosp Santa Maria, CHULN, Med Oncol Dept, Lisbon, Portugal

[4] Hosp Prof Dr Fernando Fonseca, Med Oncol Dept, Amadora, Portugal

[5] Ctr Hosp Lisboa Cent, Med Oncol Dept, Lisbon, Portugal

[6] Hosp Virgen de Valme, Pharma Dept, Seville, Spain

[7] Ctr Hosp Barreiro Montijo, Med Oncol Dept, Barreiro, Portugal

[8] Hosp Univ Puerta del Mar, Med Oncol Dept, Cadiz, Spain

[9] Fdn Arturo Lopez Perez, Unidad Cirugia Oncol & Reconstructiva Mamaria, Providencia, Chile

[10] CBIOS Univ Lusofonas Res Ctr Biosci & Hlth Techno, Lisbon, Portugal

[11] Univ Alcala, Dept Biomed Sci, Madrid, Spain

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

10.1093/neuonc/noad137.288

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P11.54.A

引用

页数：1

共 50 条

[1] Neoadjuvant treatment for HER2-positive breast cancer
Takada, Masahiro
Toi, Masakazu
CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
[2] Pertuzumab in neoadjuvant treatment of HER2-positive early breast cancer
Abraham, Jame
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2014, 12 (03): : 84 - 86
[3] Predictors of successful neoadjuvant treatment in HER2-positive breast cancer
Hannikainen, Elli-Noora
Mattson, Johanna
Karihtala, Peeter
ONCOLOGY LETTERS, 2023, 26 (04)
[4] Current neoadjuvant treatment options for HER2-positive breast cancer
Abdel-Razeq, Hikmat
Marei, Lina
BIOLOGICS-TARGETS & THERAPY, 2011, 5 : 87 - 94
[5] Treatment of brain metastases of HER2-positive breast cancer
Heudel, P.
Tredan, O.
Cassier, P.
Ray-Coquard, I.
Guastalla, J. -P.
Bachelot, T.
ONCOLOGIE, 2012, 14 (01) : 41 - 44
[6] Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer
Harbeck, Nadia
BREAST, 2022, 62 : S12 - S16
[7] Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study
Untch, Michael
Rezai, Mahdi
Loibl, Sibylle
Fasching, Peter A.
Huober, Jens
Tesch, Hans
Bauerfeind, Ingo
Hilfrich, Joern
Eidtmann, Holger
Gerber, Bernd
Hanusch, Claus
Kuehn, Thorsten
du Bois, Andreas
Blohmer, Jens-Uwe
Thomssen, Christoph
Costa, Serban Dan
Jackisch, Christian
Kaufmann, Manfred
Mehta, Keyur
von Minckwitz, Gunter
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (12) : 2024 - 2031
[8] Risk factors for brain relapse in HER2-positive metastatic breast cancer patients
Renata Duchnowska
Rafał Dziadziuszko
Bogumiła Czartoryska-Arłukowicz
Barbara Radecka
Barbara Szostakiewicz
Katarzyna Sosińska-Mielcarek
Agnieszka Karpińska
Elżbieta Starosławska
Tomasz Kubiatowski
Cezary Szczylik
Breast Cancer Research and Treatment, 2009, 117 : 297 - 303
[9] Risk factors for brain relapse in HER2-positive metastatic breast cancer patients
Duchnowska, Renata
Dziadziuszko, Rafal
Czartoryska-Arlukowicz, Bogumila
Radecka, Barbara
Szostakiewicz, Barbara
Sosinska-Mielcarek, Katarzyna
Karpinska, Agnieszka
Staroslawska, Elzbieta
Kubiatowski, Tomasz
Szczylik, Cezary
BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (02) : 297 - 303
[10] Treatment of HER2-positive breast cancer
Figueroa-Magalhaes, Maria Cristina
Jelovac, Danijela
Connolly, Roisin M.
Wolff, Antonio C.
BREAST, 2014, 23 (02): : 128 - 136

← 1 2 3 4 5 →